Sunscreen safety: The precautionary principle, the Australian Therapeutic Goods Administration and nanoparticles in sunscreens

NanoEthics

Volumn 2, Issue 3, 2008, Pages 231-240

  Faunce, Thomas ^a,b   Murray, Katherine ^a   Nasu, Hitoshi ^b   Bowman, Diana ^c  

^a The Australian National University   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Nanoparticles; Precautionary principle; Sunscreens; Therapeutic goods administration

Indexed keywords

EID: 58049200112     PISSN: 18714757     EISSN: 18714765     Source Type: Journal    
DOI: 10.1007/s11569-008-0041-z     Document Type: Article

References (59)

1. Advanced Nanotechnology Limited (2005) ZinClear - the choice is clear for cosmetic clarity and broad spectrum UV blocking. Advanced Nanotechnology, Perth
2. Cameron J (1999) The precautionary principle: Core meaning, constitutional framework and procedures for implementation. In: Harding R, Fisher E (eds) Perspectives on the precautionary principle. Federation Press, Sydney, pp 29-58
3. Cartagena Protocol on Biosafety to the Convention on Biological Diversity (2000) Int Leg Mater 39:1027
4. Commission of the European Communities (2000) Communication from the commission on the precautionary principle. Brussels, 2 February 2000), available at (last visited 1 October 2004)
5. Commonwealth of Australia (1989) Therapeutic Goods Act
6. Commonwealth of Australia (2000) Gene Technology Act (169)
7. Cross FB (1996) Paradoxical perils of the precautionary principle. Wash Lee Law Rev 53:851-925
8. Department of Health and Aging (2001) Environmental health risk assessment guidelines for assessing human health risks from environmental hazards. Department of Health and Aging
9. Dussert AS, Gooris E (1997) Characterisation of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int J Cosmet Sci 19:119-129
10. European Community (1992) The Maastricht Treaty
11. European Community (2001) Treaty Establishing the European Community, (EUR-lex)
12. Faunce T (2008) Toxicological and public good considerations for the regulation of nanomaterial-containing medical products. Expert Opin Drug Saf 7(2):103-106
13. Fisher E, Jones J, von Schomberg R (2006) Chapter 1: Implementing the precautionary principle: Perspectives and prospects. In: Fisher E, Jones J, von Schomberg R (eds) Implementing the precautionary principle: perspectives and prospects. Edward Elgar, UK, pp 1-16
14. Flinders Consulting Group (2006) A review of the potential occupational health and safety implications of nanotechnology. Department of Employment and Workplace Relations: Office of the Australian Safety and Compensation Council
15. Food and Drug Administration (2007) Nanotechnology - a report of the U.S. food and drug administration nanotechnology task force. FDA, Washington DC
16. Graham JD (2001) Decision-analytic refinements of the precautionary principle. J Risk Res 4:127-141
17. Gurr JR et al (2005) Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology 213:66-73
18. Heads of Government of the Commonwealth, States and Territories of Australia, and representatives of Local Government in Australia (1992) Intergovernmental agreement on the environment. Commonwealth Department of the Environment and Water Resources
19. Holm S, Harris J (1999) Precautionary principle stifles discovery. Nature 400:398
20. International Centre for Technology Assessment et al (2006) Citizen petition to the United States Food and Drug Administration. CTA, Washington DC
21. Jordan A, O'Riordan T (1998) The precautionary principle in contemporary environmental policy and politics. Paper given at Wingspread Conference on 'Implementing the Precautionary Principle', Racine, Wisconsin, 23-25 January
22. Kertesz ZS, Sikszai Z, Kiss AZ (2003-2004) Quality of skin as a barrier to ultra-fine particles. Nanoderm EU 5-Project in 2003-2004
23. Kimbrell GA (2006) Nanomaterial consumer products and FDA regulation: regulatory challenges and necessary amendments. Nanotech L & Bus 3(3):329-338
24. Lademann J et al (2001) Investigation of follicular penetration of topically applied substances. Skin Pharmacol Appl Skin Physiol 14:17-22
25. Lademann J et al (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247-256
26. Lademann J et al (2006) Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. doi: 10.1016/ j.ejpb.2006.10.019
27. Lansdown ABG, Taylor A (1997) Zinc and titanium oxides: Promising UV-absorbers but what influence do they have on the intact skin. Int J Cosmet Sci 19:167-172
28. Lawson A (2005) The Therapeutic Goods Administration will investigate the safety of a new sunscreen technology due to concerns it could damage skin cells. The Sydney Morning Herald, sec. Health and Fitness, 18 December
29. Maier T, Korting HC (2005) Sunscreens - which and what for. Skin Pharmacol Physiol 18(6):253-262
30. Majone G (2006) The internationalisation of regulation. In: Minogue M, Carino L (eds) Regulatory governance in developing countries. Edward Elgar, London, p 51
31. Marchant GE, Mossman KL (2004) Arbitrary and capricious: The precautionary principle in the European Union Courts. AEI Press, Washington
32. Marchant GE, Sylvester DJ (2006) Transnational models for regulation of nanotechnology. J Law Med Ethics 34:714-725
33. Miller G (2006) Nanomaterials, sunscreens and cosmetics: Small ingredients big risks. Friends of the Earth
34. Nohynek GJ, Lademann J, Ribaud C, Roberts MS (2007) Grey goo on the ski? Nanotechnology, cosmetic and suncreeen safety. Crit Rev Toxicol 37:251-277
35. NIOSH (2005a) NIOSH Pocket Guide to Chemical Hazards: Zinc Oxide. Centers for Disease Control and Prevention, Department of Health and Human Services
36. NIOSH (2005b) NIOSH Current Intelligence Bulletin: Evaluation of Health Hazard and Recommendations for Occupational exposure to Titanium Dioxide. NIOSH
37. Nollkaemper A (1996) "What you risk reveals what you value", and other dilemmas encountered in the legal assaults on risks. In: Freestone D, Hey E (eds) The precautionary principle and international law: The challenge of implementation. Kluwer Law International, The Hague, pp 73-94
38. Peel J (2006) Precautionary only in name? Tensions between precaution and risk assessment in the Australian GMO regulatory framework. In: Fisher E, Jones J, von Schomberg R (eds) Implementing the precautionary principle perspectives and prospects. Edward Elgar, London, pp 203-220
39. Pflucker F et al (1999) The outermost stratum corneum layer is an effective barrier against dermal uptake of topically applied micronized titanium dioxide. Int J Cosmet Sci 21(6):399-411
40. Randall A (2008) Taking the precautionary principle seriously, Seminar presented at the Crawford School of Economics and Governance, The Australian National University, Canberra, 15 April 2008, the audio recording available via (last visited 23 April 2008)
41. Rip A (2006) The tension between fiction and precaution in nanotechnology. In: Fisher E, Jones J, von Schomberg R (eds) Implementing the precautionary principle: Perspectives and prospects. Edward Elgar, London
42. Rouse JG et al (2007) Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 7(1):155-160
43. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2006) Penetration of intact skin by quantum dots with diverse physiochemical properties. Tox Sci 91:159-165
44. Sandin P (1999) Dimensions of the precautionary principle. HumEcol Risk Assess 5:889-907
45. Schulz J et al (2002) Distribution of sunscreens on skin. Adv Drug Deliv Rev 54(1):157-163
46. Scientific Committee on Consumer Products (2005) Scientific Committee on Consumer Products - request for a scientific option: Safety of nanomaterials in cosmetic products. Health and Consumer Protection Directorate-General, European Commission, Brussels, http://ec.europa.eu/ health/ph_risk/committees/04_sccp/docs/sccp_nano_en.pdf
47. Scientific Committee on Consumer Products (2007) Opinion on safety of nanomaterials in cosmetic products. Brussels: Health and Consumer Protection Directorate-General, European Commission
48. Sunstein CR (2005) Laws of fear: Beyond the precautionary principle. Cambridge University Press, Cambridge
49. Tan MH et al (1996) A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 37:185-187
50. The Hon. Justice Paul L Stein AM (1999) Are decision-makers too cautious with the precautionary principle? Paper given at Land and Environment Court of New South Wales Annual Conference, Peppers Hydro Majestic, Medlow Bath, Blue Mountains
51. The United Nations Conference on Environment and Development (1992) Rio Declaration on Environment and Development. United Nations Environment Programme
52. Therapeutic Goods Administration (2003) Australian regulatory guidelines for OTC medicines. Department of Health and Aging
53. Therapeutic Goods Administration (2004) Medicines Regulation and the TGA. Department of Health and Aging, Commonwealth of Australia
54. Therapeutic Goods Administration (2006a) Regulation of therapeutic goods in Australia, , accessed 24/09/2006
55. Therapeutic Goods Administration (2006b) Safety of sunscreens containing nanoparticles of zinc oxide or titanium dioxide. Department of Health and Aging, Canberra
56. Tinkle SS et al (2003) Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 111(9):1202-1208
57. Tsuji JS et al (2006) Research strategies for safety evaluation of nanomaterials, part IV: Risk assessment of nanoparticles. Toxicol Sci 89(1):42-45
58. Trouwborst A (2002) Evolution and status of the precautionary principle in international law. Kluwer Law International, The Hague
59. Vogt A et al (2006) 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol 126:1316-1322